文献速递药物不良反应与药物警戒

澳大利亚社区药房用药事件报告研究:QUMwatch 研究中用药事件的性质、严重程度与原因

The nature, severity and causes of medication incidents from an Australian community pharmacy incident reporting system: The QUMwatch study.
PubMed 文献 · Br J Clin Pharmacol · 2021-06-08

该研究在澳大利亚悉尼 30 家社区药房开展匿名的用药事件(MI)自愿报告项目,采用高级事件管理系统记录并分类事件特征、贡献因素、严重程度与频率。30 个月内共报告 1013 例事件,其中 831 例为接近错误,165 例涉及患者伤害;大部分事件发生在处方阶段(61.1%),其次为调配(25.7%)和给药(23.5%)。研究识别了多重相互关联的贡献因素,并认为通过针对优先风险与贡献因素可减少社区用药事件的发病与死亡。

要点

  • 社区药房用药事件报告项目可捕捉并刻画社区用药安全问题。
  • 多数事件为接近错误,处方阶段错误占比最高。
  • 应针对已识别的优先风险与贡献因素改进用药安全。

核心结论

  • 用药事件报告项目能够捕捉并刻画社区用药安全问题,并识别导致错误的人为与系统因素。
  • 鉴于社区用药普遍,针对本研究所识别的优先风险与贡献因素可能降低用药事件导致的发病与死亡。

研究设计与样本

  • 研究在澳大利亚悉尼的 30 家社区药房开展匿名或保密的用药事件自愿报告项目。
  • 采用高级事件管理系统(Advanced Incident Management System)记录并分类事件特征、贡献因素、严重程度与频率评分。

主要发现

  • 30 个月内共报告 1013 例事件,其中 831 例为接近错误,165 例报告涉及患者伤害。
  • 事件占比最大的年龄段为 >65 岁患者(35.7%)。
  • 多数事件涉及处方阶段错误(61.1%),其次为调配(25.7%)和给药(23.5%),部分错误发生在多个阶段(17.9%)。
  • 涉及药物类别以全身用抗菌药(12.2%)、镇痛药(11.8%)和肾素-血管紧张素类药物(11.7%)为主。
  • 贡献因素中,医疗服务提供者相关因素包括违反程序/指南(75.6%)、基于规则的错误(55.6%)和沟通(50.6%);患者相关因素包括认知因素(31.9%)、沟通(25.5%)和行为(6.1%)。

关键数值与推荐

  • 组织安全文化与风险管理流程被评为次优。

临床怎么用

  • 社区药房可建立用药事件自愿报告项目以持续监测用药安全问题。
  • 针对处方阶段错误、高风险药物类别及已识别的贡献因素优先开展改进措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Most research into medication safety has been conducted in hospital settings with less known about primary care. The aim of this study was to characterise the nature and causes of medication incidents (MIs) in the community using a pharmacy incident reporting programme. METHODS: Thirty community pharmacies participated in an anonymous or confidential MI spontaneous reporting programme in Sydney, Australia. The Advanced Incident Management System was used to record and classify incident characteristics, contributing factors, severity and frequency ratings. RESULTS: In total, 1013 incidents were reported over 30 months, 831 of which were near misses while 165 reports involved patient harm. The largest proportion of cases pertained to patients aged >65 years (35.7%). Most incidents involved errors during the prescribing stage (61.1%), followed by dispensing (25.7%) and administration (23.5%), while some errors occurred at multiple stages (17.9%). Systemic antibacterials (12.2%), analgesics (11.8%) and renin-angiotensin medicines (11.7%) formed the majority of implicated classes. Participants identified diverse and interrelating contributing factors: those concerning healthcare providers included violations to procedures/guidelines (75.6%), rule-based mistakes (55.6%) and communication (50.6%); those concerning patients included cognitive factors (31.9%), communication (25.5%) and behaviour (6.1%). Organisational safety culture and inadequate risk management processes were rated as suboptimal. CONCLUSION: An MI reporting programme can capture and characterise medication safety problems in the community and identify the human and system factors that contribute to errors. Since medicine use is ubiquitous in the community, morbidity and mortality from MIs may be reduced by addressing the prioritised risks and contributing factors identified in this study.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Adie K, Fois RA, McLachlan AJ, et al. The nature, severity and causes of medication incidents from an Australian community pharmacy incident reporting system: The QUMwatch study. Br J Clin Pharmacol. 2021. PMID: 34022060. doi:10.1111/bcp.14924

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。